Eaton Vance Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.43M | Buy |
35,908
+1,199
| +3% | +$181K | 0.01% | 753 |
|
|
2022
Q2 | $5.06M | Buy |
34,709
+4,589
| +15% | +$669K | 0.01% | 805 |
|
|
2022
Q1 | $3.57M | Buy |
30,120
+29,949
| +17,514% | +$3.55M | ﹤0.01% | 988 |
|
|
2021
Q4 | $24K | Sell |
171
-135
| -44% | -$18.9K | ﹤0.01% | 2358 |
|
|
2021
Q3 | $3K | Buy |
306
+185
| +153% | +$1.81K | ﹤0.01% | 1910 |
|
|
2021
Q2 | $12K | Buy |
+121
| New | +$12K | ﹤0.01% | 2524 |
|